Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001193125-26-161508 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 17, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
99,613
Total Value
$2,027,157.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 15, 2026 | Sale | 81,840 | $20.27 | $1,659,044.11 | 4,562,546 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Apr 16, 2026 | Sale | 11,116 | $21.10 | $234,590.95 | 4,551,430 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Apr 16, 2026 | Sale | 6,657 | $20.06 | $133,522.78 | 4,544,773 | Indirect | See footnote | View Details |